HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weigert, C. Articles by Heilig, C. W. Search for Related Content PubMed PubMed Citation Articles by Weigert, C. Articles by Heilig, C. W. Social Bookmarking                What's this?

Evidence for a Novel TGF-ß1-Independent Mechanism of Fibronectin Production in Mesangial Cells Overexpressing Glucose Transporters

¹ Department of Internal Medicine, Division of Endocrinology, Metabolism and Pathobio-Chemistry, University of Tübingen, Germany
² III Division of Nephrology, Johns Hopkins School of Medicine, Baltimore, Maryland
³ Department of Medicine, Division of Nephrology, University of Michigan Medical School, Ann Arbor, Michigan
⁴ Department of Neurology, University of Tübingen, Germany

Recent experimental work indicates that the hyperglycemia-induced increase in mesangial matrix production, which is a hallmark in the development of diabetic nephropathy, is mediated by increased expression of GLUT1. Mesangial cells stably transfected with human GLUT1 mimic the effect of hyperglycemia on the production of the extracellular matrix proteins, particularly fibronectin, when cultured under normoglycemic conditions. Our investigation of the molecular mechanism of this effect has revealed that the enhanced fibronectin production was not mediated by the prosclerotic cytokine transforming growth factor (TGF)-ß1. We found markedly increased nuclear content in Jun proteins, leading to enhanced DNA-binding activity of activating protein 1 (AP-1). AP-1 inhibition reduced fibronectin production in a dosage-dependent manner. Moreover, inhibition of classic protein kinase C (PKC) isoforms prevented both the activation of AP-1 and the enhanced fibronectin production. In contrast to mesangial cells exposed to high glucose, no activation of the hexosamine biosynthetic, p38, or extracellular signal–related kinase 1 and 2 mitogen-activated protein kinase pathways nor any increase in TGF-ß1 synthesis could be detected, which could be explained by the absence of oxidative stress in cells transfected with the human GLUT1 gene. Our data indicate that increased glucose uptake and metabolism induce PKC-dependent AP-1 activation that is sufficient for enhanced fibronectin production, but not for increased TGF-ß1 expression.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Qian, E. Feldman, S. Pennathur, M. Kretzler, and F. C. Brosius III From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy Diabetes, June 1, 2008; 57(6): 1439 - 1445. [Full Text] [PDF]

				F. Peng, D. Wu, B. Gao, A. J. Ingram, B. Zhang, K. Chorneyko, R. McKenzie, and J. C. Krepinsky RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease Diabetes, June 1, 2008; 57(6): 1683 - 1692. [Abstract] [Full Text] [PDF]

				S. P. R. Rao, R. Wassell, M. A. Shaw, and K. Sharma Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1182 - F1189. [Abstract] [Full Text] [PDF]

				W. Qi, X. Chen, J. Holian, E. Mreich, S. Twigg, R. E. Gilbert, and C. A. Pollock Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1070 - F1077. [Abstract] [Full Text] [PDF]

				C. Ricci, C. Iacobini, G. Oddi, L. Amadio, S. Menini, M. P. Rastaldi, A. Frasheri, F. Pricci, F. Pugliese, and G. Pugliese Role of TGF-{beta}/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1514 - 1524. [Abstract] [Full Text] [PDF]

				M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC Mouse Models of Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45. [Abstract] [Full Text] [PDF]

				G. Zhou, C. Li, and L. Cai Advanced Glycation End-Products Induce Connective Tissue Growth Factor-Mediated Renal Fibrosis Predominantly through Transforming Growth Factor {beta}-Independent Pathway Am. J. Pathol., December 1, 2004; 165(6): 2033 - 2043. [Abstract] [Full Text] [PDF]

				M. Haneda, D. Koya, M. Isono, and R. Kikkawa Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1374 - 1382. [Full Text] [PDF]